These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 17725302)
1. [Diffusion weighted imaging: its diagnostic and differential value for prostate cancer]. Shi H; Ding HY Zhonghua Nan Ke Xue; 2007 Jul; 13(7):605-9. PubMed ID: 17725302 [TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted imaging in normal prostate and differential diagnosis of prostate diseases. Ren J; Huan Y; Wang H; Zhao H; Ge Y; Chang Y; Liu Y Abdom Imaging; 2008; 33(6):724-8. PubMed ID: 18219519 [TBL] [Abstract][Full Text] [Related]
3. [Diffusion weighted MRI helps evaluate angiogenesis and vascular endothelial growth factor expression in prostate cancer]. Liu JG; Wang B; Wang XZ; Niu QL; Zhang Q Zhonghua Nan Ke Xue; 2009 May; 15(5):403-8. PubMed ID: 19514550 [TBL] [Abstract][Full Text] [Related]
4. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging. Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522 [TBL] [Abstract][Full Text] [Related]
5. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results. Kim CK; Park BK; Lee HM; Kwon GY Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156 [TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted imaging of prostate cancer: correlation between apparent diffusion coefficient values and tumor proliferation. Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX J Magn Reson Imaging; 2009 Jun; 29(6):1360-6. PubMed ID: 19472393 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined. Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184 [TBL] [Abstract][Full Text] [Related]
9. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. Kim JH; Kim JK; Park BW; Kim N; Cho KS J Magn Reson Imaging; 2008 Nov; 28(5):1173-9. PubMed ID: 18837000 [TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. Kim CK; Park BK; Han JJ; Kang TW; Lee HM J Comput Assist Tomogr; 2007; 31(3):449-54. PubMed ID: 17538295 [TBL] [Abstract][Full Text] [Related]
11. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. Hosseinzadeh K; Schwarz SD J Magn Reson Imaging; 2004 Oct; 20(4):654-61. PubMed ID: 15390142 [TBL] [Abstract][Full Text] [Related]
12. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. Kim CK; Park BK; Kim B AJR Am J Roentgenol; 2010 Jan; 194(1):W33-7. PubMed ID: 20028888 [TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted imaging of normal and malignant prostate tissue at 3.0T. Pickles MD; Gibbs P; Sreenivas M; Turnbull LW J Magn Reson Imaging; 2006 Feb; 23(2):130-4. PubMed ID: 16374882 [TBL] [Abstract][Full Text] [Related]
14. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. Kim CK; Park BK; Lee HM J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194 [TBL] [Abstract][Full Text] [Related]
15. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. Issa B J Magn Reson Imaging; 2002 Aug; 16(2):196-200. PubMed ID: 12203768 [TBL] [Abstract][Full Text] [Related]
16. An intravoxel incoherent motion diffusion-weighted imaging study of prostate cancer. Shinmoto H; Tamura C; Soga S; Shiomi E; Yoshihara N; Kaji T; Mulkern RV AJR Am J Roentgenol; 2012 Oct; 199(4):W496-500. PubMed ID: 22997399 [TBL] [Abstract][Full Text] [Related]
17. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. Tamada T; Sone T; Jo Y; Toshimitsu S; Yamashita T; Yamamoto A; Tanimoto D; Ito K J Magn Reson Imaging; 2008 Sep; 28(3):720-6. PubMed ID: 18777532 [TBL] [Abstract][Full Text] [Related]
18. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer]. Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042 [TBL] [Abstract][Full Text] [Related]
19. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones. Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Morgan VA; Kyriazi S; Ashley SE; DeSouza NM Acta Radiol; 2007 Jul; 48(6):695-703. PubMed ID: 17611881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]